Literature DB >> 23553836

Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration.

Zihui Xu1, Mickael Poidevin, Xuekun Li, Yujing Li, Liqi Shu, David L Nelson, He Li, Chadwick M Hales, Marla Gearing, Thomas S Wingo, Peng Jin.   

Abstract

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) share phenotypic and pathologic overlap. Recently, an expansion of GGGGCC repeats in the first intron of C9orf72 was found to be a common cause of both illnesses; however, the molecular pathogenesis of this expanded repeat is unknown. Here we developed both Drosophila and mammalian models of this expanded hexanucleotide repeat and showed that expression of the expanded GGGGCC repeat RNA (rGGGGCC) is sufficient to cause neurodegeneration. We further identified Pur α as the RNA-binding protein of rGGGGCC repeats and discovered that Pur α and rGGGGCC repeats interact in vitro and in vivo in a sequence-specific fashion that is conserved between mammals and Drosophila. Furthermore, overexpression of Pur α in mouse neuronal cells and Drosophila mitigates rGGGGCC repeat-mediated neurodegeneration, and Pur α forms inclusions in the fly eye expressing expanded rGGGGCC repeats, as well as in cerebellum of human carriers of expanded GGGGCC repeats. These data suggest that expanded rGGGGCC repeats could sequester specific RNA-binding protein from their normal functions, ultimately leading to cell death. Taken together, these findings suggest that the expanded rGGGGCC repeats could cause neurodegeneration, and that Pur α may play a role in the pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.

Entities:  

Keywords:  RNA-mediated neurodegeneration; fly model

Mesh:

Substances:

Year:  2013        PMID: 23553836      PMCID: PMC3651485          DOI: 10.1073/pnas.1219643110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Kinesin transports RNA: isolation and characterization of an RNA-transporting granule.

Authors:  Yoshimitsu Kanai; Naoshi Dohmae; Nobutaka Hirokawa
Journal:  Neuron       Date:  2004-08-19       Impact factor: 17.173

2.  Prevalence and patterns of cognitive impairment in sporadic ALS.

Authors:  G M Ringholz; S H Appel; M Bradshaw; N A Cooke; D M Mosnik; P E Schulz
Journal:  Neurology       Date:  2005-08-23       Impact factor: 9.910

Review 3.  RNA-mediated neuromuscular disorders.

Authors:  Laura P W Ranum; Thomas A Cooper
Journal:  Annu Rev Neurosci       Date:  2006       Impact factor: 12.449

4.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

5.  The overlap of amyotrophic lateral sclerosis and frontotemporal dementia.

Authors:  Catherine Lomen-Hoerth; Thomas Anderson; Bruce Miller
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

Review 6.  Axonal transport defects: a common theme in neurodegenerative diseases.

Authors:  Subhojit Roy; Bin Zhang; Virginia M-Y Lee; John Q Trojanowski
Journal:  Acta Neuropathol       Date:  2005-01-12       Impact factor: 17.088

7.  RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila.

Authors:  Peng Jin; Daniela C Zarnescu; Fuping Zhang; Christopher E Pearson; John C Lucchesi; Kevin Moses; Stephen T Warren
Journal:  Neuron       Date:  2003-08-28       Impact factor: 17.173

8.  Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.

Authors:  Ian R A Mackenzie; Eileen H Bigio; Paul G Ince; Felix Geser; Manuela Neumann; Nigel J Cairns; Linda K Kwong; Mark S Forman; John Ravits; Heather Stewart; Andrew Eisen; Leo McClusky; Hans A Kretzschmar; Camelia M Monoranu; J Robin Highley; Janine Kirby; Teepu Siddique; Pamela J Shaw; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2007-05       Impact factor: 10.422

9.  The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS.

Authors:  Kohji Mori; Shih-Ming Weng; Thomas Arzberger; Stephanie May; Kristin Rentzsch; Elisabeth Kremmer; Bettina Schmid; Hans A Kretzschmar; Marc Cruts; Christine Van Broeckhoven; Christian Haass; Dieter Edbauer
Journal:  Science       Date:  2013-02-07       Impact factor: 47.728

10.  Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Authors:  A H Brand; N Perrimon
Journal:  Development       Date:  1993-06       Impact factor: 6.868

View more
  164 in total

1.  Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity.

Authors:  J Gavin Daigle; Karthik Krishnamurthy; Nandini Ramesh; Ian Casci; John Monaghan; Kevin McAvoy; Earl W Godfrey; Dianne C Daniel; Edward M Johnson; Zachary Monahan; Frank Shewmaker; Piera Pasinelli; Udai Bhan Pandey
Journal:  Acta Neuropathol       Date:  2016-01-04       Impact factor: 17.088

Review 2.  New pathologic mechanisms in nucleotide repeat expansion disorders.

Authors:  C M Rodriguez; P K Todd
Journal:  Neurobiol Dis       Date:  2019-06-21       Impact factor: 5.996

Review 3.  C9orf72: At the intersection of lysosome cell biology and neurodegenerative disease.

Authors:  Joseph Amick; Shawn M Ferguson
Journal:  Traffic       Date:  2017-03-23       Impact factor: 6.215

Review 4.  Mechanisms of toxicity in C9FTLD/ALS.

Authors:  Tania F Gendron; Veronique V Belzil; Yong-Jie Zhang; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2014-01-07       Impact factor: 17.088

5.  Stress Granule Assembly Disrupts Nucleocytoplasmic Transport.

Authors:  Ke Zhang; J Gavin Daigle; Kathleen M Cunningham; Alyssa N Coyne; Kai Ruan; Jonathan C Grima; Kelly E Bowen; Harsh Wadhwa; Peiguo Yang; Frank Rigo; J Paul Taylor; Aaron D Gitler; Jeffrey D Rothstein; Thomas E Lloyd
Journal:  Cell       Date:  2018-04-05       Impact factor: 41.582

6.  Repeat-associated non-ATG (RAN) translation.

Authors:  John Douglas Cleary; Amrutha Pattamatta; Laura P W Ranum
Journal:  J Biol Chem       Date:  2018-09-13       Impact factor: 5.157

7.  C9orf72 Dipeptide Repeats Cause Selective Neurodegeneration and Cell-Autonomous Excitotoxicity in Drosophila Glutamatergic Neurons.

Authors:  Wangchao Xu; Jin Xu
Journal:  J Neurosci       Date:  2018-07-23       Impact factor: 6.167

Review 8.  Role of the C9ORF72 Gene in the Pathogenesis of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.

Authors:  Zongbing Hao; Rui Wang; Haigang Ren; Guanghui Wang
Journal:  Neurosci Bull       Date:  2020-08-29       Impact factor: 5.203

9.  Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD.

Authors:  Shuangxi Li; Zhihao Wu; Ishaq Tantray; Yu Li; Songjie Chen; Jason Dong; Steven Glynn; Hannes Vogel; Michael Snyder; Bingwei Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

10.  C9orf72 hypermethylation protects against repeat expansion-associated pathology in ALS/FTD.

Authors:  Elaine Y Liu; Jenny Russ; Kathryn Wu; Donald Neal; Eunran Suh; Anna G McNally; David J Irwin; Vivianna M Van Deerlin; Edward B Lee
Journal:  Acta Neuropathol       Date:  2014-05-08       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.